Aikido Pharma is developing a drug portfolio to treat acute lymphoblastic leukemia (ALL). cancer along with three other main cancer types. Our drug portfolio combined with AIkido Pharma Inc. ’s platform offers a robust drug pipeline focused on the development and commercialization of drugs to treat unmet medical needs in oncology. Get in touch with Aikido Pharma today by calling 212-745-1373.
Meet Aikido Pharma A BioTechnology Development Company Focused on The Treatment Of Early and Mid-Stage Small-Molecule Anti-Cancer Therapeutics